Clinical and Provider Resources

Histiocyte Society

The Histiocyte Society, a nonprofit organization, is a group of more than 200 physicians and scientists from around the world committed to improving the lives of patients with histiocytic disorders by conducting clinical and laboratory research into the causes and treatment of this disease.   More >

Histio-Care Network guidelines for Diagnosis of Histiocytic Disorders

The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease.

Do you have a case to discuss at our monthly Histio-Care Network meeting?

Please note that this is purely educational and does not constitute a medical opinion. Due to the high volume of requests, we may not be able to provide a slot for every submission. Please note that the meeting occurs every second Thursday at noon-1pm central US time.

Histio-Care Network Treatment Guidelines

coming soon…

Erdheim-Chester disease Consensus Guidelines

Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era.

Webinars:

Histio-Care Network Treatment Guidelines

coming soon…

Histiocyte Society

The Histiocyte Society, a nonprofit organization, is a group of more than 200 physicians and scientists from around the world committed to improving the lives of patients with histiocytic disorders by conducting clinical and laboratory research into the causes and treatment of this disease.   More >

Adult Langerhans cell histiocytosis Consensus Guidelines

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.

National Comprehensive Cancer Center Network Guidelines for Histiocytic Neoplasms

Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.